Content area
Full Text
Eur J Clin Pharmacol (2006) 62: 159160DOI 10.1007/s00228-005-0074-yLETTER TO THE EDITORMark Naunton . Michiel Duyvendak .
Gregory M. Peterson . Jacobus R. J. B. BrouwersComments on Glintborg et al.s drugdrug interactions study
(EJCP 2005; 61:675681)Received: 19 October 2005 / Accepted: 14 November 2005 / Published online: 12 January 2006
# Springer-Verlag 2006Dear Editor,The results from the recent study by Glintborg et al. [1] are
not surprising (lack of significant drug-drug interactions in
patients recently discharged from hospital). It is expected
that clinically important interactions are identified while
the patient is in hospital, with one of the offending agents
stopped or changed to a safer alternative before discharge.
Furthermore, any clinically important interactions are
likely to be identified by the patients community pharmacist, who alerts the general practitioner and prevents possible harm before the prescription is even dispensed.We find it hard to agree with the authors conclusion that
screening for potential interactions in hospital is probably
not cost-effective based on the results of this study-the
interview and screening in this study occurred in the
patients home setting after hospitalisation. Are the authors
suggesting that reviewing patients medications...